P. Nilyanimit

发表

CRISPR/Cas9-mediated gene deletion of the ompA gene in symbiotic Cedecea neteri impairs biofilm formation and reduces gut colonization of Aedes aegypti mosquitoes

E. Kozlova, G. Hughes, Shivanand Hegde, 2019, PLoS neglected tropical diseases.

CRISPR/Cas9-mediated gene deletion of the ompA gene in an Enterobacter gut symbiont impairs biofilm formation and reduces gut colonization of Aedes aegypti mosquitoes

E. Kozlova, G. Hughes, Shivanand Hegde, 2018, bioRxiv.

A community intervention effectiveness study of single dose or two doses of bivalent HPV vaccine (CERVARIX®) in female school students in Thailand

S. Rerks-Ngarm, Nakorn Premsri, C. Namwat, 2022, PloS one.

Molecular epidemiology of the first wave of severe acute respiratory syndrome coronavirus 2 infection in Thailand in 2020

Rungrueng Kitphati, K. Suwannakarn, Y. Poovorawan, 2020, Scientific Reports.

Persistence of immunity against Omicron BA.1 and BA.2 variants following homologous and heterologous COVID-19 booster vaccines in healthy adults after a two-dose AZD1222 vaccination

S. Honsawek, Y. Poovorawan, J. Mongkolsapaya, 2022, International Journal of Infectious Diseases.

Immune responses to inactivated and vector-based vaccines in individuals previously infected with SARS-CoV-2

Y. Poovorawan, N. Wanlapakorn, R. Yorsaeng, 2022, medRxiv.

Effects of boosted mRNA and adenoviral‐vectored vaccines on immune responses to omicron BA.1 and BA.2 following the heterologous CoronaVac/AZD1222 vaccination

Y. Poovorawan, J. Puenpa, J. Mongkolsapaya, 2022, medRxiv.

Neutralizing Activities against the Omicron Variant after a Heterologous Booster in Healthy Adults Receiving Two Doses of CoronaVac Vaccination

S. Honsawek, Y. Poovorawan, J. Mongkolsapaya, 2022, medRxiv.

Comparison of the reactogenicity and immunogenicity between two-dose mRNA COVID-19 vaccine and inactivated followed by an mRNA vaccine in children aged 5 - 11 years

Y. Poovorawan, N. Wanlapakorn, R. Yorsaeng, 2022, medRxiv.

Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (CovovaxTM) after homologous and heterologous two-dose regimens

S. Honsawek, Y. Poovorawan, N. Wanlapakorn, 2022, International Journal of Infectious Diseases.

Covovax TM ) after homologous and heterologous two-dose regimens

S. Honsawek, Y. Poovorawan, N. Wanlapakorn, 2022 .

Immunogenicity Following Two Doses of the BBIBP-CorV Vaccine and a Third Booster Dose with a Viral Vector and mRNA COVID-19 Vaccines against Delta and Omicron Variants in Prime Immunized Adults with Two Doses of the BBIBP-CorV Vaccine

Y. Poovorawan, N. Wanlapakorn, R. Yorsaeng, 2022, medRxiv.

Human Papillomavirus in Thai Women and Men with Anogenital Warts

Y. Poovorawan, J. Srisomboon, J. Chansaenroj, 2019, Intervirology.

Comparison of Four Human Papillomavirus Genotyping Methods: Next-generation Sequencing, INNO-LiPA, Electrochemical DNA Chip, and Nested-PCR

K. Praianantathavorn, Y. Poovorawan, S. Payungporn, 2017, Annals of laboratory medicine.

Detection of human papillomavirus in male and female urine by electrochemical DNA chip and PCR sequencing.

S. Niruthisard, Y. Poovorawan, N. Phanuphak, 2013, Asian Pacific journal of cancer prevention : APJCP.

Role of a homozygous A(TA)₇TAA promoter polymorphism and an exon 1 heterozygous frameshift mutation UGT1A1 in Crigler-Najjar syndrome type II in a Thai neonate.

Y. Poovorawan, V. Chongsrisawat, P. Nilyanimit, 2013, Genetics and molecular research : GMR.

Compound heterozygosity of a novel exon 3 frameshift (p.R357P fs*24) mutation and Y486D mutation in exon 5 of the UGT1A1 gene in a Thai infant with Crigler-Najjar syndrome type 2.

Y. Poovorawan, N. Wanlapakorn, P. Nilyanimit, 2015, Genetics and molecular research : GMR.

Prevalence of HPV infection among Thai schoolgirls in the north-eastern provinces in 2018: implications for HPV immunization policy

S. Rerks-Ngarm, Nakorn Premsri, C. Namwat, 2023, IJID Regions.

Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine

S. Honsawek, Y. Poovorawan, N. Wanlapakorn, 2021, medRxiv.

Immunogenicity and durability against Omicron BA.1, BA.2 and BA.4/5 variants at 3–4 months after a heterologous COVID-19 booster vaccine in healthy adults with a two-doses CoronaVac vaccination

S. Honsawek, Y. Poovorawan, J. Mongkolsapaya, 2022, medRxiv.

Strong Correlations between the Binding Antibodies against Wild-Type and Neutralizing Antibodies against Omicron BA.1 and BA.2 Variants of SARS-CoV-2 in Individuals Following Booster (Third-Dose) Vaccination

Y. Poovorawan, J. Mongkolsapaya, T. Duangchinda, 2022, medRxiv.

COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron

Y. Poovorawan, J. Puenpa, T. Duangchinda, 2022, medRxiv.

Neutralizing Activities against the Omicron Variant after a Heterologous Booster in Healthy Adults Receiving Two Doses of CoronaVac Vaccination.

S. Honsawek, Y. Poovorawan, J. Mongkolsapaya, 2022, The Journal of infectious diseases.

The Fourth Dose of mRNA COVID-19 Vaccine Following 12 Different Three-Dose Regimens: Safety and Immunogenicity to Omicron BA.4/BA.5

S. Honsawek, Y. Poovorawan, N. Wanlapakorn, 2023, medRxiv.

Immunogenicity of the BNT162b2 COVID-19 vaccine as a third dose (booster) following two doses of different primary series regimens in Thailand

Y. Poovorawan, N. Wanlapakorn, R. Yorsaeng, 2022, Pathogens and global health.

Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine

S. Honsawek, Y. Poovorawan, J. Mongkolsapaya, 2022, Vaccine.

Comparison of human papillomavirus (HPV) detection in urine and cervical swab samples using the HPV GenoArray Diagnostic assay

Y. Poovorawan, J. Chansaenroj, A. Karalak, 2017, PeerJ.

'HWHFWLRQRI+XPDQ3DSLOORPDYLUXVLQ0DOHDQG)HPDOH8ULQH E\(OHFWURFKHPLFDO'1$&KLSDQG3&56HTXHQFLQJ

Y. Poovorawan, N. Wanlapakorn, N. Gemma, 2013 .

Detection Sensitivity for HPV between Self-Collected Vaginal Swabs and Physician-Collected Cervical Swabs

S. Niruthisard, Y. Poovorawan, N. Wanlapakorn, 2015 .

Comparison of detection sensitivity for human papillomavirus between self-collected vaginal swabs and physician-collected cervical swabs by electrochemical DNA chip.

P. Nilyanimit, 2015, Asian Pacific journal of cancer prevention : APJCP.

Lack of HPV in pterygium with no evidence of autoinoculation and the role of cytokines in pterygium with dry eye

N. Kasetsuwan, Y. Poovorawan, Y. Chongpison, 2021, Scientific Reports.

An amino acid substitution in HCV core antigen limits its use as a reliable measure of HCV infection compared with HCV RNA

Y. Poovorawan, P. Kongtawelert, N. Posuwan, 2023, PloS one.

SARS-CoV-2 Antibody Dynamics after COVID-19 Vaccination and Infection: A Real-World Cross-Sectional Analysis

Y. Poovorawan, N. Wanlapakorn, R. Yorsaeng, 2023, Vaccines.

Comparison of the reactogenicity and immunogenicity between two‐dose mRNA COVID‐19 vaccine and inactivated COVID‐19 vaccine followed by an mRNA vaccine in children aged 5−11 years

Y. Poovorawan, T. Duangchinda, N. Wanlapakorn, 2023, Journal of medical virology.

Qualitative hepatitis C virus RNA assay identifies active infection with sufficient viral load for treatment among Phetchabun residents in Thailand

Y. Poovorawan, Rujipat Wasitthankasem, N. Wanlapakorn, 2022, medRxiv.

Interkingdom interactions shape the fungal microbiome of mosquitoes

G. Hughes, Shivanand Hegde, E. Hornett, 2023, bioRxiv.

Comparable detection of HPV using real-time PCR in paired cervical samples and concentrated first-stream urine collected with Colli-Pee device

J. Excler, S. Vongpunsawad, S. Chaithongwongwatthana, 2023, Diagnostic microbiology and infectious disease.

Development of a simplified and cost-effective sample preparation method for genotyping of human papillomavirus by next-generation sequencing

K. Praianantathavorn, Y. Poovorawan, S. Payungporn, 2023, Archives of Virology.